HealthDay - TUESDAY, April 28 (HealthDay News) -- Certain gene alterations improve breast cancer patients' response to anthracycline therapy, Canadian researchers say.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.